A presenter at the Crohn’s & Colitis Congress outlined some of the newer therapies that have expanded the current “arsenal of tools” for the treatment of inflammatory bowel disease.
“When we think about these therapies, we know that they have truly revolutionized our management of patients with inflammatory bowel disease,” David Choi, PharmD, clinical pharmacy specialist and associate director at the University of Chicago Inflammatory Bowel Disease Center, said. “The landscape really has improved, and more and more therapies have come to market. … But I think sometimes we can be a little hesitant to use some of these newer therapies, because there’s a lot of unknown about it. So, you stick with what you’re comfortable with.”